Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Academic Licensing Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: SYN046
MIFTS: 45

Syndrome of Inappropriate Antidiuretic Hormone

Categories: Rare diseases, Endocrine diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Syndrome of Inappropriate Antidiuretic Hormone

About this section

MalaCards integrated aliases for Syndrome of Inappropriate Antidiuretic Hormone:

Name: Syndrome of Inappropriate Antidiuretic Hormone 53
Inappropriate Adh Syndrome 53 73
Dilutional Hyponatremia 53 73
Siadh 53 55
Syndrome of Inappropriate Antidiuretic Hormone Secretion 53
Schwartz Bartter Syndrome 53

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Endocrine diseases
See all MalaCards categories (disease lists)


External Ids:

UMLS 73 C0585109
Sources

Summaries for Syndrome of Inappropriate Antidiuretic Hormone

About this section
NIH Rare Diseases : 53 Syndrome of inappropriate antidiuretic hormone (SIADH) occurs when an excessive amount of antidiuretic hormone is released resulting in water retention and a low sodium level. It is most common among older people. It has many causes including, but not limited too, pain, stress, exercise, a low blood sugar level, certain disorders of the heart, thyroid gland, kidneys, or adrenal glands, and the use of certain medications. Disorders of the lungs and certain cancers may increase the risk of developing SIADH. Treatment includes fluid restriction and sometimes the use of medications that decrease the effect of antidiuretic hormone on the kidneys.

MalaCards based summary : Syndrome of Inappropriate Antidiuretic Hormone, also known as inappropriate adh syndrome, is related to nephrogenic syndrome of inappropriate antidiuresis and malignant hypertension, and has symptoms including polyuria An important gene associated with Syndrome of Inappropriate Antidiuretic Hormone is AVP (Arginine Vasopressin), and among its related pathways/superpathways are Aquaporin-mediated transport and G alpha (s) signalling events. The drugs Tolvaptan and Empagliflozin have been mentioned in the context of this disorder. Affiliated tissues include lung, heart and thyroid, and related phenotypes are behavior/neurological and homeostasis/metabolism

Sources

Related Diseases for Syndrome of Inappropriate Antidiuretic Hormone

About this section

Diseases related to Syndrome of Inappropriate Antidiuretic Hormone via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 223)
# Related Disease Score Top Affiliating Genes
1 nephrogenic syndrome of inappropriate antidiuresis 32.4 AVP AVPR2
2 malignant hypertension 30.8 ACE NPPA
3 acute myocardial infarction 30.4 ACE NPPA NPPB
4 inappropriate adh syndrome 30.4 AQP2 AVP AVPR2 POMC
5 small cell cancer of the lung 30.3 AVP CHGA POMC
6 myocardial infarction 29.4 ACE ALB NPPA NPPB
7 liver cirrhosis 29.3 ALB AQP2 NPPA
8 congestive heart failure 29.0 ACE AQP2 NPPA NPPB
9 diabetes insipidus 28.9 AQP2 AVP AVPR2 POMC
10 myxedema 10.8 AVP NPPA
11 central sleep apnea 10.8 NPPA NPPB
12 renal artery disease 10.7 ACE NPPA
13 hypertension, diastolic 10.7 ACE NPPA
14 mitral valve stenosis 10.7 NPPA NPPB
15 vasculogenic impotence 10.7 ACE NPPA
16 syncope 10.7 NPPA NPPB
17 aortic valve insufficiency 10.7 ACE NPPB
18 diastolic heart failure 10.6 ACE NPPB
19 benign essential hypertension 10.6 ALB AVP
20 ischemic heart disease 10.6 ACE NPPB
21 paralytic ileus 10.6 ALB AVP
22 constrictive pericarditis 10.6 ALB NPPB
23 central nervous system germinoma 10.6 AVP POMC
24 tuberculous epididymitis 10.6 AVP POMC
25 central nervous system germ cell tumor 10.6 AVP POMC
26 systolic heart failure 10.5 ACE NPPB
27 pure autonomic failure 10.5 ACE NPPA
28 olfactory nerve neoplasm 10.5 AVP CHGA
29 tricuspid valve insufficiency 10.5 ALB NPPB
30 secondary hypertrophic osteoarthropathy 10.5 AVP POMC
31 granulomatous hepatitis 10.5 ACE AVP
32 orthostatic proteinuria 10.5 ACE ALB
33 renovascular hypertension 10.5 ACE NPPA
34 hypertensive nephropathy 10.5 ACE ALB
35 anuria 10.5 ACE ALB
36 central nervous system organ benign neoplasm 10.5 AVP POMC
37 acute kidney tubular necrosis 10.5 ALB NPPA
38 cranial nerve malignant neoplasm 10.5 AVP CHGA
39 analbuminemia 10.5 ALB AVP
40 hypertensive heart disease 10.5 ACE NPPB
41 pericardial effusion 10.4 NPPA NPPB
42 bronchus cancer 10.4 AVP AVPR2
43 primary hepatic neuroendocrine carcinoma 10.4 CHGA VIM
44 chordoid meningioma 10.4 CHGA VIM
45 mitral valve insufficiency 10.4 ACE NPPA NPPB
46 premenstrual tension 10.4 AVP POMC
47 aortic valve disease 2 10.4 ACE NPPA NPPB
48 lung cancer 10.4
49 glossopharyngeal neuralgia 10.4 POMC VIM
50 chromophobe adenoma 10.4 AVP POMC

Graphical network of the top 20 diseases related to Syndrome of Inappropriate Antidiuretic Hormone:



Diseases related to Syndrome of Inappropriate Antidiuretic Hormone
Sources

Symptoms & Phenotypes for Syndrome of Inappropriate Antidiuretic Hormone

About this section

UMLS symptoms related to Syndrome of Inappropriate Antidiuretic Hormone:


polyuria

MGI Mouse Phenotypes related to Syndrome of Inappropriate Antidiuretic Hormone:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.7 ACE APLN AQP2 AVP AVPR2 POMC
2 homeostasis/metabolism MP:0005376 9.65 ACE ALB APLN AQP2 AVP AVPR2
3 renal/urinary system MP:0005367 9.23 AVPR2 CHGA NPPA POMC ACE ALB
Sources

Drugs & Therapeutics for Syndrome of Inappropriate Antidiuretic Hormone

About this section

Drugs for Syndrome of Inappropriate Antidiuretic Hormone (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 29)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tolvaptan Approved Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable 150683-30-0 216237
2
Empagliflozin Approved Phase 2, Phase 3,Phase 3 864070-44-0
3 Natriuretic Agents Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
4 Hormones Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
5 Vasopressins Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
6 Arginine Vasopressin Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
7
Satavaptan Phase 3,Phase 2 185913-78-4 7029
8 Coagulants Phase 3,Phase 1,Phase 2
9 Hemostatics Phase 3,Phase 1,Phase 2
10 Deamino Arginine Vasopressin Phase 2, Phase 3
11 Hormone Antagonists Phase 3,Phase 1,Phase 2
12 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 1,Phase 2
13 Vasoconstrictor Agents Phase 3,Phase 1,Phase 2
14 Hypoglycemic Agents Phase 2, Phase 3,Phase 3
15 Pharmaceutical Solutions Phase 2, Phase 3
16 arginine Nutraceutical Phase 3,Phase 1,Phase 2
17
Probenecid Approved, Investigational Phase 1, Phase 2 57-66-9 4911
18
Acetylcysteine Approved, Investigational Phase 1, Phase 2 616-91-1 12035
19 Renal Agents Phase 1, Phase 2
20 Respiratory System Agents Phase 1, Phase 2
21 N-monoacetylcystine Phase 1, Phase 2
22 Expectorants Phase 1, Phase 2
23 Antidotes Phase 1, Phase 2
24 Anti-Infective Agents Phase 1, Phase 2
25 Antioxidants Phase 1, Phase 2
26 Protective Agents Phase 1, Phase 2
27 Antirheumatic Agents Phase 1, Phase 2
28 Antiviral Agents Phase 1, Phase 2
29 cysteine Nutraceutical Phase 1, Phase 2

Interventional clinical trials:

(show all 22)
# Name Status NCT ID Phase Drugs
1 Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic Medicine Withdrawn NCT00298753 Phase 4
2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia Unknown status NCT01507727 Phase 2, Phase 3 Tolvaptan;Placebo
3 Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Completed NCT00264914 Phase 3 SR121463B
4 Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Completed NCT00264927 Phase 3 SR121463B
5 Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study Completed NCT02729766 Phase 2, Phase 3 Empagliflozin 25mg Tbl;Placebo P-Tablet
6 "SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia Completed NCT00201994 Phase 3 Tolvaptan
7 “SALT Trial” Study of Ascending Levels of Tolvaptan in Hyponatremia Completed NCT00072683 Phase 3 tolvaptan
8 A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH Recruiting NCT03048747 Phase 3 Tolvaptan Oral Tablet
9 Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study Recruiting NCT03202667 Phase 2, Phase 3 Empagliflozin 25mg;Placebo
10 Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study Enrolling by invitation NCT02874807 Phase 2, Phase 3 Empagliflozin
11 A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia Terminated NCT00728091 Phase 3 Satavaptan;placebo
12 Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia Terminated NCT01227512 Phase 3 tolvaptan
13 A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Completed NCT02009878 Phase 1, Phase 2 tolvaptan
14 Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Completed NCT00032734 Phase 2 satavaptan (SR121463B)
15 Overcoming Membrane Transporters to Improve CNS Drug Delivery - Improving Brain Antioxidants After Traumatic Brain Injury Completed NCT01322009 Phase 1, Phase 2 Probenecid and N-acetyl cysteine;Placebo
16 Subclassification of the Syndrome of Inappropriate ADH Secretion Completed NCT01341665
17 An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH Completed NCT02545101
18 An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain Completed NCT02548845
19 An Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in Italy Completed NCT02573077
20 Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia Completed NCT01240668
21 Evaluation of Plasma Volume Using Ultrasound in Disorders of Fluid With Sodium Active, not recruiting NCT01547650
22 Fractional Urate Excretion in Nonedematous Hyponatremia Withdrawn NCT01425125 Not Applicable Tolvaptan in euvolemic hyponatremia

Search NIH Clinical Center for Syndrome of Inappropriate Antidiuretic Hormone

Sources

Genetic Tests for Syndrome of Inappropriate Antidiuretic Hormone

About this section
Sources

Anatomical Context for Syndrome of Inappropriate Antidiuretic Hormone

About this section

MalaCards organs/tissues related to Syndrome of Inappropriate Antidiuretic Hormone:

41
Lung, Heart, Thyroid, Kidney, Adrenal Gland, Prostate, Brain
Sources

Publications for Syndrome of Inappropriate Antidiuretic Hormone

About this section

Articles related to Syndrome of Inappropriate Antidiuretic Hormone:

(show top 50) (show all 376)
# Title Authors Year
1
Cisplatin-induced syndrome of inappropriate antidiuretic hormone secretion (SIADH) with life-threatening hyponatraemia. ( 29386213 )
2018
2
Mild water restriction with or without urea for the longterm treatment of syndrome of inappropriate antidiuretic hormone secretion (SIADH): Can urine osmolality help the choice? ( 29017746 )
2018
3
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) ( 29939554 )
2018
4
Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone. ( 29629516 )
2018
5
Successful Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Neuro-Sweet Disease in Myelodysplastic Syndrome. ( 29225251 )
2018
6
Successful treatment by tolvaptan of the syndrome of inappropriate antidiuretic hormone secretion that may be associated with chemotherapy-induced tumour lysis in a patient with small-cell lung carcinoma. ( 29796276 )
2018
7
Strongyloides Hyperinfection and Miliary Tuberculosis Presenting with Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Malnourished Patient. ( 29796361 )
2018
8
Syndrome of inappropriate antidiuretic hormone secretion associated with seronegative neuromyelitis optica spectrum disorder. ( 28393003 )
2017
9
Filling the Gap - Improving Awareness and Practice in Hyponatraemia and the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in the Older Patient: A European Consensus View. ( 27701711 )
2017
10
Syndrome of inappropriate antidiuretic hormone secretion induced by the phytotherapy Harpagophytum procumbers: case report. ( 28355406 )
2017
11
Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Amyotrophic Lateral Sclerosis in a Patient Developing Carbon Dioxide Narcosis. ( 28381746 )
2017
12
Syndrome of Inappropriate Antidiuretic Hormone Consecutive to treatment with Ciprofloxacin. ( 28786821 )
2017
13
Neuroendocrine Carcinoma of the Breast With Endobronchial Metastases and Syndrome of Inappropriate Antidiuretic Hormone Secretion. ( 28420584 )
2017
14
A Rare Presentation of the Syndrome of Inappropriate Antidiuretic Hormone in a 12-year old Female as the Initial Presentation of an Immature Ovarian Teratoma. ( 28818586 )
2017
15
Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials. ( 28251822 )
2017
16
Syndrome of inappropriate antidiuretic hormone accompanied by bilateral hypothalamic and anterior thalamic lesions with serum antiaquaporin 4 antibody. ( 28432042 )
2017
17
Bortezomib as a probable cause of the syndrome of inappropriate antidiuretic hormone secretion: A case report and review of the literature. ( 28856001 )
2017
18
Low-dose tolvaptan PK/PD: comparison of patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion to healthy adults. ( 28803333 )
2017
19
Syndrome of Inappropriate Antidiuretic Hormone Secretion Complicating Systemic Nocardiosis in a Renal Transplant Recipient: A Case Report. ( 29198680 )
2017
20
Pure small cell recurrent prostate cancer developing syndrome of inappropriate antidiuretic hormone secretion. ( 28623637 )
2017
21
Morvan syndrome: a rare cause of syndrome of inappropriate antidiuretic hormone secretion. ( 28781533 )
2017
22
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Associated with Mediastinal Schwannoma. ( 29399023 )
2017
23
Syndrome of inappropriate antidiuretic hormone associated with rectal small cell neuroendocrine carcinoma: a case report. ( 28852457 )
2017
24
"Syndrome of Inappropriate Antidiuretic Hormone Secretion" as a Diagnostic and a Prognostic Indicator in Olfactory Neuroblastoma. ( 28670560 )
2017
25
Syndrome of inappropriate antidiuretic hormone secretion following irinotecan-cisplatin administration as a treatment for recurrent ovarian clear cell carcinoma. ( 28217682 )
2017
26
Syndrome of inappropriate antidiuretic hormone secretion in a dog with a histiocytic sarcoma. ( 28698689 )
2017
27
Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Mini-Breed Puppy Associated With Aspiration Pneumonia. ( 29525234 )
2017
28
Effect of single-dose of tolvaptan in neurocritical patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion. ( 28087091 )
2017
29
Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Patient with Mucosa-associated Lymphoid Tissue Lymphoma. ( 29021471 )
2017
30
Recurrent syndrome of inappropriate antidiuretic hormone secretion due to tolterodine in an elderly male patient. ( 28540903 )
2017
31
Hypertrophic Pachymeningitis and the Syndrome of Inappropriate Antidiuretic Hormone Secretion: Coincidence or Cause? ( 28245481 )
2017
32
Syndrome of inappropriate antidiuretic hormone secretion from concomitant use of itraconazole and vindesine. ( 28782144 )
2017
33
Basaloid Squamous Cell Carcinoma of the Lung Associated With Syndrome of Inappropriate Antidiuretic Hormone Secretion. ( 29317964 )
2017
34
Lack of appropriate investigations in making a diagnosis of syndrome of inappropriate antidiuretic hormone. ( 28260255 )
2017
35
A Case Report of Syndrome of Inappropriate Antidiuretic Hormone Induced by Pregabalin. ( 28275386 )
2016
36
Split Hand Syndrome and Syndrome of Inappropriate Antidiuretic Hormone. ( 26763519 )
2016
37
Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion. ( 26584969 )
2016
38
Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Poor Prognosis in Small-cell Lung Cancer. ( 26706100 )
2016
39
Autoimmune Limbic Encephalitis and Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Lamotrigine-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. ( 27181555 )
2016
40
Morvan's syndrome with anti contactin associated protein like 2 - voltage gated potassium channel antibody presenting with syndrome of inappropriate antidiuretic hormone secretion. ( 27695240 )
2016
41
Development of syndrome of inappropriate antidiuretic hormone secretion (SIADH) after Onyx embolisation of a cavernous carotid fistula. ( 27013230 )
2016
42
Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Associated with Myeloma and Syndrome of Inappropriate Antidiuretic Hormone Secretion in an Elderly Man. ( 27550802 )
2016
43
The syndrome of inappropriate antidiuretic hormone secretion after giant leaf frog (Phyllomedusa bicolor) venom exposure. ( 27421671 )
2016
44
Syndrome of Inappropriate Antidiuretic Hormone Associated with Eosinophilic Granulomatosis with Polyangiitis. ( 27150880 )
2016
45
Syndrome of inappropriate antidiuretic hormone secretion in a case of olfactory neuroblastoma without anti-diuretic hormone immunoreactivity: A case report and review of the literature. ( 28010942 )
2016
46
Development of syndrome of inappropriate antidiuretic hormone secretion (SIADH) after Onyx embolisation of a cavernous carotid fistula. ( 27001597 )
2016
47
Clozapine improved the syndrome of inappropriate antidiuretic hormone secretion in a patient with treatment-resistant schizophrenia. ( 27539233 )
2016
48
Syndrome of Inappropriate Antidiuretic Hormone in a Patient Receiving High-Dose Haloperidol and Quetiapine Therapy. ( 27093387 )
2016
49
Yield of workup for patients with idiopathic presentation of the syndrome of inappropriate antidiuretic hormone secretion. ( 27016871 )
2016
50
The Syndrome of Inappropriate Antidiuretic Hormone after Transthoracic Needle Biopsy in Non-Small-Cell Lung Cancer. ( 27726441 )
2016
Sources

Variations for Syndrome of Inappropriate Antidiuretic Hormone

About this section
Sources

Expression for Syndrome of Inappropriate Antidiuretic Hormone

About this section
Search GEO for disease gene expression data for Syndrome of Inappropriate Antidiuretic Hormone.
Sources

Pathways for Syndrome of Inappropriate Antidiuretic Hormone

About this section

Pathways related to Syndrome of Inappropriate Antidiuretic Hormone according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Aquaporin-mediated transport 66
Show member pathways
 11.85 AQP2 AVP AVPR2
2
G alpha (s) signalling events 66
11.3 AVP AVPR2 POMC
3
Cardiomyocyte Differentiation through BMP Receptors 64
10.5 NPPA NPPB
4
Vasopressin-regulated water reabsorption 37
10.44 AQP2 AVP AVPR2
Sources

GO Terms for Syndrome of Inappropriate Antidiuretic Hormone

About this section

Cellular components related to Syndrome of Inappropriate Antidiuretic Hormone according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.56 ACE ALB APLN AVP CHGA NPPA
2 secretory granule GO:0030141 9.33 AVP CHGA POMC
3 mast cell granule GO:0042629 9.26 CHGA NPPA
4 extracellular space GO:0005615 9.23 ACE ALB APLN AVP CHGA NPPA

Biological processes related to Syndrome of Inappropriate Antidiuretic Hormone according to GeneCards Suite gene sharing:

(show all 14)
# Name GO ID Score Top Affiliating Genes
1 regulation of signaling receptor activity GO:0010469 9.65 APLN AVP NPPA NPPB POMC
2 sodium-independent organic anion transport GO:0043252 9.54 ALB AVP
3 excretion GO:0007588 9.52 AQP2 AVPR2
4 positive regulation of vasoconstriction GO:0045907 9.51 AVP AVPR2
5 cGMP biosynthetic process GO:0006182 9.49 NPPA NPPB
6 regulation of the force of heart contraction GO:0002026 9.48 APLN CHGA
7 water transport GO:0006833 9.46 AQP2 AVP
8 regulation of blood vessel diameter GO:0097746 9.43 ACE NPPB
9 positive regulation of cardiac muscle contraction GO:0060452 9.4 CHGA NPPA
10 receptor guanylyl cyclase signaling pathway GO:0007168 9.37 NPPA NPPB
11 renal water homeostasis GO:0003091 9.33 AQP2 AVP AVPR2
12 positive regulation of systemic arterial blood pressure GO:0003084 9.32 AVP AVPR2
13 regulation of blood vessel size GO:0050880 9.13 AVP NPPA NPPB
14 regulation of blood pressure GO:0008217 9.02 ACE CHGA NPPA NPPB POMC

Molecular functions related to Syndrome of Inappropriate Antidiuretic Hormone according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signaling receptor binding GO:0005102 9.55 APLN AVP NPPA NPPB POMC
2 hormone receptor binding GO:0051427 9.26 NPPA NPPB
3 neuropeptide hormone activity GO:0005184 9.13 AVP NPPA POMC
4 hormone activity GO:0005179 9.02 APLN AVP NPPA NPPB POMC
Sources

Sources for Syndrome of Inappropriate Antidiuretic Hormone

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....